2020/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2020, Issue 3, 2020, Issue 3

Commentary

Quality standards for biopharmaceuticals: the importance of good manufacturing practice

Original Research

Qualitative survey-based evaluation of operability and convenience for the etanercept biosimilar YLB113 in a unique injection pen in patients with rheumatoid arthritis

Systematic analysis of injection-site pain and reactions caused by subcutaneous administration of the adalimumab biosimilar FKB327 versus the adalimumab reference product via different delivery methods

European prescribers’ attitudes and beliefs on biologicals prescribing and automatic substitution

Regulatory

Pelmeg®, a biosimilar pegfilgrastim developed in the context of evolving regulatory guidelines

Meeting Report

3rd Colombian educational workshop on regulatory assessment of biosimilars 2019 – Report

Source URL: https://gabi-journal.net/2020-3-gabi-journal-table-of-contents.html